1 unchanged sentence
Securities Trading Plans of Directors and Executive Officers
−Removed: On November 17, 2023 , Robin E.
−Removed: Lampkin , Ashland’s Senior Vice President, General Counsel and Corporate Secretary , entered into a Rule 10b5-1 trading arrangement that provides for the sale of 844 shares of Ashland Common Stock.
−Removed: The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
−Removed: The duration of the trading arrangement is until the earlier of (1) February 29, 2024 , (2) the date on which all transactions under the trading arrangement are completed, or (3) at such time as the trading arrangement is otherwise terminated or expires according to its terms.
+Added: On February 16, 2024 , Eric N.
+Added: Boni , Ashland’s Vice President, Finance and Principal Accounting Officer , entered into a Rule 10b5-1 trading arrangement, to exercise up to 2,730 stock appreciation rights related to Ashland’s common stock.
+Added: The duration of the trading arrangement is until the earlier of (1) December 5, 2024 , (2) the date on which all transactions under the trading arrangement are completed, or (3) at such time as the trading arrangement is otherwise terminated or expires according to its terms.
Ashland Securities Trading Plans
−Removed: During November 2023 , Ashland entered into a Rule 10b5-1 trading arrangement to repurchase Ashland Common Stock under its 2023 Stock Repurchase Program, in the aggregate dollar amount of $100 million.
−Removed: The trading arrangement was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
−Removed: The trading arrangement terminated in December 2023 , upon the completion of the purchase of 1,238,212 shares of Ashland Common Stock.
Amended and Restated Articles of Incorporation of Ashland Global Holdings Inc.
6 unchanged sentences
333-211719) and incorporated by reference herein).
−Removed: Receivables Purchase Agreement, dated October 19, 2023 (filed as Exhibit 10.1 to Ashland’s Form 8-K filed on October 24, 2023 (SEC File No.
−Removed: 333-211719), and incorporated herein by reference).
−Removed: Master Framework Agreement, dated October 19, 2023 (filed as Exhibit 10.2 to Ashland’s Form 8-K filed on October 24, 2023 (SEC File No.
−Removed: 333-211719), and incorporated herein by reference).
−Removed: Letter Agreement between the Ashland and Guillermo Novo, dated November 15, 2023.
Certificate of Guillermo Novo, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
8 unchanged sentences
Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language):
−Removed: (i) Statements of Consolidated Comprehensive Income (Loss) for the three months ended December 31, 2023 and December 31, 2022;
−Removed: (ii) Condensed Consolidated Balance Sheets at December 31, 2023 and September 30, 2023;
−Removed: (iii) Statements of Condensed Consolidated Cash Flows for the three months ended December 31, 2023 and December 31, 2022;
+Added: (i) Statements of Consolidated Comprehensive Income (Loss) for the three and six months ended March 31, 2024 and March 31, 2023;
+Added: (ii) Condensed Consolidated Balance Sheets at March 31, 2024 and September 30, 2023;
+Added: (iii) Statements of Condensed Consolidated Cash Flows for the six months ended March 31, 2024 and March 31, 2023;
and (iv) Notes to Condensed Consolidated Financial Statements.
2 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: January 31, 2024
Senior Vice President and Chief Financial Officer
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.